AKR1C3 is a biomarker and druggable target for oropharyngeal tumors

Volume: 44, Issue: 2, Pages: 357 - 372
Published: Nov 19, 2020
Abstract
Oropharynx squamous cell carcinoma (OPSCC) is a subtype of head and neck squamous cell carcinoma (HNSCC) arising from the base of the tongue, lingual tonsils, tonsils, oropharynx or pharynx. The majority of HPV-positive OPSCCs has a good prognosis, but a fraction of them has a poor prognosis, similar to HPV-negative OPSCCs. An in-depth understanding of the molecular mechanisms underlying OPSCC is mandatory for the identification of novel...
Paper Details
Title
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors
Published Date
Nov 19, 2020
Volume
44
Issue
2
Pages
357 - 372
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.